Statewide
Delaware Office of Emergency Medical Services
Delaware Office of Emergency Medical Services (DE) carries 35 drugs across 113 dose entries in its current published protocol, effective 2024-11-01.
Drugs and doses35
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 975–1000 mg | PO | not captured | standing | page 80 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 80 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 33 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 58 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 5 mg | NEB | not captured | standing | page 16 |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | page 16 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 150 mg | IV | not captured | standing | page 30 |
| STEMI | adult | 150 mg | IV | not captured | standing | page 31 |
| Narrow-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 33 |
| Narrow-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 34 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 42 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 42 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 30 |
| STEMI | adult | 324 mg | PO | not captured | standing | page 31 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5 mg | IV/IM | not captured | standing | page 75 |
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 32 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 57 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 21 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asystole / PEA | adult | 1 g | IV | not captured | standing | page 44 |
| Bradycardia | adult | 1 g | IV | not captured | standing | page 32 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 68 |
| Narrow-complex tachycardia | adult | 1 g | IV | not captured | standing | page 33 |
| Narrow-complex tachycardia | adult | 1 g | IV | not captured | standing | page 34 |
| VF / pulseless VT | adult | 1 g | IV | not captured | standing | page 42 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | page 19 |
| Hypoglycemia | peds | 5 mL/kg | IV | not captured | standing | page 19 |
| Seizure | adult | 25 g | IV/IO | not captured | standing | page 25 |
| Seizure | peds | 5 mL/kg | IV/IO | not captured | standing | page 25 |
| Stroke | adult | 25 g | IV | not captured | standing | page 23 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV | not captured | standing | page 33 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 50 mg | IV/IM | not captured | standing | page 75 |
| Allergic reaction | adult | 50 mg | IV/IM/PO | not captured | standing | page 26 |
| Allergic reaction | peds | 1 mg/kg | IV/IM/PO | not captured | standing | page 26 |
| Anaphylaxis | adult | 50 mg | IV/IM | not captured | standing | page 26 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 26 |
| Dystonic reaction | adult | 50 mg | IV/IM/PO | not captured | standing | page 27 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM | not captured | standing | page 75 |
| Nausea / vomiting | adult | 1.25 mg | IV | not captured | standing | page 14 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 26 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 26 |
| Bradycardia | adult | 2–10 mcg | IV | not captured | standing | page 32 |
| Bradycardia | peds | 0.01 mg/kg | IV | not captured | standing | page 32 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 42 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 42 |
| Croup | peds | 0.5 mL/kg | NEB | not captured | standing | page 52 |
| Respiratory distress | adult | 0.5 mg | IM | not captured | standing | page 16 |
| Respiratory distress | peds | 0.01 mg/kg | IM | not captured | standing | page 16 |
Esmolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| VF / pulseless VT | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 42 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.1 mg/kg (max 10 mg) | IV | not captured | standing | page 34 |
| Narrow-complex tachycardia | peds | 0.2 mg/kg (max 10 mg) | IV | not captured | standing | page 34 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 50–100 mcg | IV/IM/IN | not captured | standing | page 80 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IM/IN | not captured | standing | page 80 |
| Post-intubation sedation | adult | 100 mcg | IV | not captured | standing | page 78 |
| Post-intubation sedation | peds | 2 mcg/kg | IV | not captured | standing | page 78 |
| STEMI | adult | 200 mcg | IV/IM | not captured | standing | page 31 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | page 19 |
| Hypoglycemia | peds | 0.5–1 mg | IM/IN | not captured | standing | page 19 |
| Stroke | adult | 1 mg | IM/IN | not captured | standing | page 23 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 71 |
| Cyanide poisoning | peds | 2.5 g | IV | not captured | standing | page 71 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 16 |
| Respiratory distress | peds | 0.25 mg | NEB | not captured | standing | page 16 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg/kg | IM | not captured | standing | page 75 |
| Agitation | peds | 5 mg/kg | IM | not captured | standing | page 75 |
| Cardiac arrest | adult | 0.5 mg/kg (max 50 mg) | IV/IO | not captured | standing | page 36 |
| Cardiac arrest | peds | 0.5 mg/kg (max 50 mg) | IV/IO | not captured | standing | page 36 |
| Severe pain | adult | 0.25 mg/kg (max 25 mg) | IV | not captured | standing | page 80 |
| RSI paralysis | adult | 2 mg/kg | IV/IO | not captured | standing | page 78 |
| RSI paralysis | peds | 2 mg/kg | IV/IO | not captured | standing | page 78 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IM | not captured | standing | page 80 |
| Severe pain | peds | 0.5 mg/kg (max 15 mg) | IV/IM | not captured | standing | page 80 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 20 mg | IV | not captured | standing | page 22 |
| Other | adult | 10 mg | IV | not captured | standing | page 22 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 20–40 mg | IO | not captured | standing | page 14 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 14 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 16 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | page 16 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV | not captured | standing | page 22 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV | not captured | standing | page 25 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 42 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 42 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IM | not captured | standing | page 26 |
| Anaphylaxis | peds | 2 mg/kg | IV/IM | not captured | standing | page 26 |
| Respiratory distress | adult | 125 mg | IV/IM | not captured | standing | page 16 |
| Respiratory distress | peds | 2 mg/kg | IV/IM | not captured | standing | page 16 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | page 33 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM | not captured | standing | page 75 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 75 |
| Post-intubation sedation | adult | 2–5 mg | IV | not captured | standing | page 78 |
| Post-intubation sedation | peds | 0.2 mg/kg | IV | not captured | standing | page 78 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 25 |
| Seizure | adult | 5 mg | IV | not captured | standing | page 25 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 25 |
| Seizure | peds | 0.2 mg/kg | IV | not captured | standing | page 25 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 2 mg | IV/IM/IN | not captured | standing | page 20 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 20 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 30 |
| CHF / pulmonary edema | adult | 0.8 mg | SL | not captured | standing | page 17 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IM/ODT | not captured | standing | page 14 |
| Nausea / vomiting | adult | 4–8 mg | IV/ODT | not captured | standing | page 21 |
| Nausea / vomiting | peds | 2 mg | IV/IM/ODT | not captured | standing | page 14 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–24 g | PO | not captured | standing | page 19 |
| Hypoglycemia | adult | 15–24 g | PO | not captured | standing | page 19 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 60 mg | PO | not captured | standing | page 16 |
| Respiratory distress | peds | 2 mg/kg | PO | not captured | standing | page 16 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 77 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 77 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asystole / PEA | adult | 50 mEq | IV | not captured | standing | page 44 |
| VF / pulseless VT | adult | 50 mEq | IV | not captured | standing | page 42 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 g | not captured | not captured | standing | page 27 |
| Obstetric hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 68 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 65 |
| Trauma / hemorrhage | peds | 15 mg/kg (max 1 g) | IV/IO | not captured | standing | page 65 |